Amrize Ltd (NYSE:AMRZ - Get Free Report)'s share price reached a new 52-week low on Thursday. The company traded as low as $36.75 and last traded at $36.7230, with a volume of 712856 shares traded. The stock had previously closed at $37.39.
Wall Street Analysts Forecast Growth
Several research analysts recently issued reports on the company. Bank of America reaffirmed an "underperform" rating and set a $40.00 target price (down from $50.00) on shares of Amrize in a research report on Wednesday, September 2nd. JPMorgan Chase & Co. lowered Amrize from an "overweight" rating to a "neutral" rating and dropped their price target for the stock from $57.00 to $52.00 in a research note on Wednesday, September 2nd. Morgan Stanley set a $63.00 price objective on shares of Amrize and gave the company an "overweight" rating in a report on Monday, June 22nd. DA Davidson initiated coverage on shares of Amrize in a research report on Monday, August 24th. They issued a "neutral" rating and a $50.00 price objective for the company. Finally, UBS Group dropped their target price on shares of Amrize from $57.00 to $42.00 and set a "neutral" rating on the stock in a research report on Tuesday, September 22nd. One investment analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eight have given a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Amrize has an average rating of "Hold" and an average target price of $53.24.
Get Our Latest Stock Analysis on AMRZ
Amrize Stock Down 1.4%
The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73. The firm has a market capitalization of $20.39 billion, a price-to-earnings ratio of 16.98, a price-to-earnings-growth ratio of 1.32 and a beta of 0.04. The business has a fifty day moving average price of $44.10 and a two-hundred day moving average price of $50.33.
Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The business had revenue of $3.49 billion during the quarter. On average, equities analysts expect that Amrize Ltd will post 2.46 earnings per share for the current year.
Amrize Dividend Announcement
The firm also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize's dividend payout ratio (DPR) is 20.28%.
Insider Activity at Amrize
In other Amrize news, Director Jacques Sanche bought 4,150 shares of Amrize stock in a transaction dated Wednesday, August 26th. The stock was acquired at an average cost of $45.02 per share, with a total value of $186,833.00. Following the purchase, the director directly owned 9,766 shares in the company, valued at $439,665.32. This represents a 73.90% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Mario Gross acquired 3,568 shares of the firm's stock in a transaction on Tuesday, August 11th. The shares were bought at an average cost of $46.60 per share, for a total transaction of $166,268.80. Following the completion of the acquisition, the insider owned 38,485 shares of the company's stock, valued at approximately $1,793,401. This represents a 10.22% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought a total of 48,983 shares of company stock valued at $2,158,755 in the last ninety days. 0.54% of the stock is currently owned by company insiders.
Institutional Trading of Amrize
A number of institutional investors have recently made changes to their positions in the company. Caldwell Sutter Capital Inc. lifted its holdings in Amrize by 11.5% in the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company's stock valued at $150,000 after purchasing an additional 275 shares in the last quarter. Baldwin Investment Management LLC raised its position in shares of Amrize by 4.4% in the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company's stock valued at $486,000 after buying an additional 375 shares during the last quarter. Mengis Capital Management Inc. lifted its stake in shares of Amrize by 8.5% in the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company's stock worth $311,000 after buying an additional 450 shares in the last quarter. Norman Fields Gottscho Capital Management LLC lifted its stake in shares of Amrize by 4.3% in the second quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company's stock worth $614,000 after buying an additional 475 shares in the last quarter. Finally, MCF Advisors LLC acquired a new position in Amrize during the fourth quarter worth about $27,000.
About Amrize
(
Get Free Report)
Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.
The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.
Amrize was established as the result of the separation of Holcim's North American business and began operating as an independent, publicly traded company in 2025.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Amrize, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amrize wasn't on the list.
While Amrize currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.